Pharmacological inhibition of mTORC1 reduces neural death and damage volume after MCAO by modulating microglial reactivity
Abstract Ischemic stroke is a sudden and acute disease characterized by neuronal death, increment of reactive gliosis (reactive microglia and astrocytes), and a severe inflammatory process. Neuroinflammation is an early event after cerebral ischemia, with microglia playing a leading role. Reactive m...
Main Authors: | Mario Villa-González, Marina Rubio, Gerardo Martín-López, Paula R. Mallavibarrena, Laura Vallés-Saiz, Denis Vivien, Francisco Wandosell, Maria José Pérez-Álvarez |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-04-01
|
Series: | Biology Direct |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13062-024-00470-5 |
Similar Items
-
mTORC1 and mTORC2 Levels in Patients With Psoriasis
by: İlayda Esna Gülsunay, et al.
Published: (2024-10-01) -
Dopamine neuron morphology and output are differentially controlled by mTORC1 and mTORC2
by: Polina Kosillo, et al.
Published: (2022-07-01) -
Microglial SIRT1 activation attenuates synapse loss in retinal inner plexiform layer via mTORC1 inhibition
by: Ke Yao, et al.
Published: (2023-09-01) -
mTORC1 and mTORC2 are differentially engaged in the development of laser-induced CNV
by: Jin Young Yang, et al.
Published: (2019-06-01) -
mTORC1 is necessary but mTORC2 and GSK3β are inhibitory for AKT3-induced axon regeneration in the central nervous system
by: Linqing Miao, et al.
Published: (2016-03-01)